African Journal of Medicine and Pharma Research

AJMPR is an open-access, peer-reviewed, abstracted and indexed, half-yearly international journal. This journal is indexed with globally recognized databases. African Journal of Medicine and Pharma Research (AJMPR) welcome the submission of manuscripts that meet the general criteria of scientific significance and excellence. The manuscript reference number will be mailed to the corresponding author within 24 hours after submission.

All submitted manuscripts should be original and unpublished elsewhere in part or entirety in the same or different languages. They also should not be under review by other scientific journals for publication. Our journal aims to produce and propagate knowledge on recent advances in medicine and pharma research.

Aim and Scope

The African Journal of Medicine and Pharma Research is dedicated to advancing knowledge in the fields of medicine and pharmaceutical sciences by publishing high-quality, peer-reviewed research. The journal covers a broad range of topics including anatomy, anesthesiology and the use of animal models. It also focuses on bioinformatics, biotechnology, Chemical Biology and biochemistry, cancer biology, therapeutic oncology, cancer research, cardiovascular research, cell and molecular biology, structural and functional biology,cell and tissue research, cell biology, chemical biology, pharmacy, disease mechanisms, therapeutic strategies, and medical innovation. The journal also addresses critical issues related to healthcare delivery and African health challenges.

The journal accepts the publication of original articles, review articles, short communications, case reports, and editorials, providing a platform for diverse contributions to the advancement of medical and pharmaceutical research.

Journal Ethics

The journal is committed to upholding the highest standards of ethical behaviour at all stages of publication. We strictly adhere to industry associations such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE), and World Association of Medical Editors (WAME), which set standards and provide guidelines for best practices in order to meet these requirements. To know more about specific policies regarding duplicate publication, conflict of interest, patient consent, etc., please visit the author guidelines

Open Access (OA) Publication

The journal promotes open access publishing that can be refers to free, unrestricted online access to research outputs such as journals, articles and books. OA content is open to all without any accessing fees without paying a subscription charge. Articles are freely available immediately after publication without any registration. This means that researchers, students, readers, scholars, and any layperson from anywhere and anytime have rapid access to the latest research content via the Innovative Open Access (OA) Policy. For more details and information, visit: www.ipinnovative.com/open-access-journals

Creative Commons Licensing

The journal is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License (CC BY-NC-SA 4.0), which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. This license allows authors to grant certain permissions to others while retaining certain rights for themselves.

Repository Policy

Authors can deposit their published articles in any repository. After publication of the article in the journal, authors are allowed and encouraged to submit their content online (for example, in institutional repositories or on their website). As this can result in fruitful discussions and earlier and more frequent citations of published work which can help to promote the accessibility and reproducibility of research findings for others.

 

Copyright of the published material

The journal takes a signed copy of the consent declaration form from the authors where they sign and accept responsibility for releasing this material to the publisher on behalf of any and all co-authors. But author retains the copyright of the content and transfers all the licensing and publishing rights to the publisher. The author grants the publisher the only right to commercially utilize the article. For the duration of the copyright's full legal term, they provide the publisher, exclusive right, and license to publish. This transfer of publication rights covers the non-exclusive right to reproduction and distribute the article, including reprints, translations, photographic, reproductions, microform, electronic form (offline, online) or any other reproduction of similar nature.

Plagiarism

Self-plagiarism is the redundant reuse of your own work, “use another’s production without crediting the sources,” or “present as new and original an idea or product derived from an existing source.” The AJMPR also considers “self-plagiarism” as a form of plagiarism. An example of self-plagiarism would be when an author borrows from his or her own previously published work without the proper citation within the newly submitted manuscript. We provide iThenticate software to our editor and reviewers as a part of our manuscript submission system.

Digital Archiving

Digital archiving ensures the preservation and accessibility of digital content over time, safeguarding it from technological changes and data loss. We prioritize the longevity and integrity of our journal by utilizing leading digital archiving services Portico and CLOCKSS. Our journal is securely preserved and remain accessible to researchers, educators, and the public, today and in the future.

 

AI Guidelines

In research and learning, human judgement is essential to validate conclusions, address bias, and ensure ethical standards. Feedback from users is key, ensuring AI enhances human creativity and intellect, rather than replacing it.

AI guidelines are designed to guide authors in addressing ethical and technical aspects of AI usage for more...

 

Advertising Policy

The Journal retains the discretion to decline any advertisement that does not meet journal's advertising policy.

1. Advertisements will not be accepted if they are indecent, offensive, or discriminatory based on personal, racial, ethnic, sexual orientation, or religious grounds, whether in text or artwork.

2. The Journal will not accept advertisements for products or services known to be harmful to health, such as tobacco and alcohol.

3. Product advertorials will not allow any treatment-specific or drug-specific campaigns to target specific articles related to the advertised products.

The presence of advertisements or product information on the Journal's website does not means endorsement or approval by the Journal or its publisher regarding the quality or claims made by the manufacturer of the advertised products. Editorial decision does not depend on the any advertisement visible on the website.

 

Ahead of Print Policy

Articles published online under the “Ahead of Print” model are considered published and can be cited and quoted using DOI as the reference source. Innovative Publication has a policy that changes WILL NOT be made after the publication of an article. Unless an accepted procedure for making corrections to the scientific record is followed.

Revenue Sources

African Journal of Medicine and Pharma Research is a self-financed open access journal, which is published in both online and print versions. Article publication charges levied on authors are the only source of income that is utilized in maintaining the administrative and print charges. Also, the very least part of revenue comes from advertisements and subscriptions.

The APC is based on an adjusted scale, providing reduced rates for low- and middle-income countries on the publication charges. Operating expense including the cost of web presence, print version, pre-press preparations, and staff salaries is supported by the above-mentioned resources.

IESRF has outsourced all pre-publication, publication, and post-publication processes to the publisher, including APC management.

About Publisher

 IP Innovative Publication Private Limited, is a well-established publisher headquartered in New Delhi, India. IP has a reputed specialization in medical, dental, nursing, and pharmacy subjects and has more than 225 books and 50 journals in its portfolio. It was founded in April 2011 and has become a well-respected medical publisher in India that fully supports many of the popular open-access models through its peer-review management system. Researchers, students, scholars, clinicians, and other healthcare professionals access Innovative journals from around the globe to educate themselves about new and innovative discoveries and to improve patient care. For more info about the publisher, click here

Innovative Specialization

Print and Online Scholarly Publisher, Peer-review system, Specialized in Medical, Dental, Nursing, and Pharmacy books and Journals as an Open Access (OA) Publisher.